MedTrace Logo

Effectiveness and Safety of YVOIRE Y-Solution 540

NCT04855188 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 394

Last updated 2024-12-19

No results posted yet for this study

Summary

To Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 540 versus YVOIRE volume plus in Nasolabial Folds Injection

Conditions

  • Wrinkles in the Nasolabial Folds

Interventions

DEVICE

YVOIRE Y-Solution 540

Injection into the deep dermis layer and/or subcutaneous layer in the nasolabial folds based on the randomization assignment.

DEVICE

YVOIRE volume plus

Injection into the deep dermis layer and/or subcutaneous layer in the nasolabial folds based on the randomization assignment.

Sponsors & Collaborators

  • LG Chem

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-07-01
Primary Completion
2022-09-29
Completion
2024-07-14

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04855188 on ClinicalTrials.gov